Literature DB >> 19178644

The upregulation of cystatin C in human gingival fibroblasts stimulated with cyclosporine A.

C-H Tsai1, S-F Yang, F-M Huang, Y-C Chang.   

Abstract

BACKGROUND AND
OBJECTIVE: Cystatin C is a 13 kDa non-glycosylated, basic protein belonging to the cystatin family. It is consistently and dramatically upregulated in a variety of fibrotic diseases. However, little is known about the correlation between cystatin C and cyclosporine A-induced gingival overgrowth. The aim of this study was to compare cystatin C expression in normal, healthy gingival tissues and cyclosporine A-induced gingival overgrowth specimens and further explore the potential mechanism that may result in cystatin C expression.
MATERIAL AND METHODS: Fifteen cyclosporine A-induced gingival overgrowth specimens and five normal gingival tissues were examined by immunohistochemistry. Three human gingival fibroblast (HGF) strains were established from crown-lengthening surgery. The reverse transcriptase-polymerase chain reaction was used to investigate the effects on HGFs exposed to cyclosporine A. In addition, predominant periodontal pathogens (Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis) and proinflammatory cytokines (interleukin-1alpha and tumor necrosis factor-alpha) were added to seek the possible regulatory mechanisms of cystatin C expression.
RESULTS: The cystatin C staining in gingival tissue was stronger in the cyclosporine A-induced gingival overgrowth group than in the normal gingival group (p < 0.05). Intensive staining for cystatin C expression was observed mainly in the cytoplasm of fibroblasts, epithelial cells and inflammatory cells. Moreover, cystatin C expression was significantly higher in cyclosporine A-induced gingival overgrowth specimens with higher levels of inflammatory infiltrates (p < 0.05). A concentration of 200 ng/mL cyclosporine A was found to increase cystatin C expression in HGFs in a time-dependent manner (p < 0.05). The addition of periodontal pathogens and proinflammatory cytokines significantly increased the expression of cystatin C compared with cyclosporine A alone (p < 0.05).
CONCLUSION: The increased ability of protein accumulation by cystatin C is one of several factors mediating cyclosporine A-induced gingival overgrowth. In addition, cyclosporine A may predispose to gingival overgrowth in inflammatory environments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19178644     DOI: 10.1111/j.1600-0765.2008.01147.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  6 in total

Review 1.  Cystatin C: Its role in pathogenesis of OSMF.

Authors:  P C Anila Namboodiripad
Journal:  J Oral Biol Craniofac Res       Date:  2014-03-17

2.  Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway.

Authors:  Yuji Kan; Tamaki Okabayashi; Shin-ichi Yokota; Soh Yamamoto; Nobuhiro Fujii; Toshiharu Yamashita
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

Review 3.  Endothelial cells and cathepsins: Biochemical and biomechanical regulation.

Authors:  Manu O Platt; W Andrew Shockey
Journal:  Biochimie       Date:  2015-10-13       Impact factor: 4.079

4.  The regulation of Oct4 in human gingival fibroblasts stimulated by cyclosporine A: Preliminary observations.

Authors:  Cheng-Chia Yu; Chia-Ming Liu; Tai-Chen Lin; Ni-Yu Su; Li-Chiu Yang; Yu-Chao Chang
Journal:  J Dent Sci       Date:  2019-12-27       Impact factor: 2.080

5.  Upregulation of embryonic stem cell marker Nanog in human gingival fibroblasts stimulated with cyclosporine A: An in vitro study.

Authors:  Cheng-Chia Yu; Ni-Yu Su; Chia-Ming Liu; Li-Chiu Yang; Chung-Hung Tsai; Yu-Chao Chang
Journal:  J Dent Sci       Date:  2016-12-24       Impact factor: 2.080

Review 6.  Cystatin C is a disease-associated protein subject to multiple regulation.

Authors:  Yuekang Xu; Ying Ding; Xinchen Li; Xiaobing Wu
Journal:  Immunol Cell Biol       Date:  2015-02-03       Impact factor: 5.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.